发明名称 |
Systems and methods for treatment planning based on plaque progression and regression curves |
摘要 |
Systems and methods are disclosed for evaluating a patient with vascular disease. One method includes receiving patient-specific data regarding a geometry of the patient's vasculature; creating an anatomic model representing at least a portion of a location of disease in the patient's vasculature based on the received patient-specific data; identifying one or more changes in geometry of the anatomic model based on a modeled progression or regression of disease at the location; calculating one or more values of a blood flow characteristic within the patient's vasculature using a computational model based on the identified one or more changes in geometry of the anatomic model; and generating an electronic graphical display of a relationship between the one or more values of the calculated blood flow characteristic and the identified one or more changes in geometry of the anatomic model. |
申请公布号 |
US9239905(B1) |
申请公布日期 |
2016.01.19 |
申请号 |
US201514621129 |
申请日期 |
2015.02.12 |
申请人 |
HeartFlow, Inc. |
发明人 |
Sankaran Sethuraman;Taylor Charles A.;Choi Gilwoo;Schaap Michiel;Zarins Christopher K.;Grady Leo J. |
分类号 |
G06F19/26;G06F19/00 |
主分类号 |
G06F19/26 |
代理机构 |
Bookoff McAndrews, PLLC |
代理人 |
Bookoff McAndrews, PLLC |
主权项 |
1. A computer-implemented method of evaluating a patient with vascular disease, the method comprising:
receiving patient-specific data regarding a geometry of the patient's vasculature; determining a plaque remodeling characteristic characterizing a propensity of the disease in the patient's vasculature to progress or regress; determining, using the received patient-specific data and the determined plaque remodeling characteristic, a geometric model of a progression or regression of disease at a location in the patient's vasculature; calculating a value of a blood flow characteristic within the patient's vasculature using a blood flow model determined based on the received patient-specific data and the determined plaque remodeling characteristic; and generating a treatment recommendation or risk assessment based on the value of the blood flow characteristic calculated using the blood flow model based on the received patient-specific data and the determined plaque remodeling characteristic. |
地址 |
Redwood City CA US |